Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1973 1
1976 1
1978 3
1979 4
1980 3
1981 2
1982 3
1983 2
1984 4
1985 6
1986 4
1987 4
1988 6
1989 4
1990 8
1991 7
1992 4
1993 6
1994 7
1995 8
1996 6
1997 10
1998 7
1999 9
2000 8
2001 9
2002 6
2003 13
2004 10
2005 11
2006 10
2007 5
2008 5
2009 12
2010 14
2011 17
2012 17
2013 13
2014 11
2015 11
2016 16
2017 21
2018 15
2019 22
2020 24
2021 20
2022 13
2023 10
2024 16
2025 18
2026 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

435 results

Results by year

Citations

5 articles found by citation matching

Search results

Filters applied: . Clear all
Page 1
Anti-Glomerular Basement Membrane Disease.
McAdoo SP, Pusey CD. McAdoo SP, et al. Clin J Am Soc Nephrol. 2017 Jul 7;12(7):1162-1172. doi: 10.2215/CJN.01380217. Epub 2017 May 17. Clin J Am Soc Nephrol. 2017. PMID: 28515156 Free PMC article. Review.
The majority of patients develop widespread glomerular crescent formation, presenting with features of rapidly progressive GN, and 40%-60% will have concurrent alveolar hemorrhage. Treatment aims to rapidly remove pathogenic autoantibody, typically with the use of plasma e …
The majority of patients develop widespread glomerular crescent formation, presenting with features of rapidly progressive GN, and 40%-60% w …
Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases.
Rovin BH, Adler SG, Barratt J, Bridoux F, Burdge KA, Chan TM, Cook HT, Fervenza FC, Gibson KL, Glassock RJ, Jayne DRW, Jha V, Liew A, Liu ZH, Mejía-Vilet JM, Nester CM, Radhakrishnan J, Rave EM, Reich HN, Ronco P, Sanders JF, Sethi S, Suzuki Y, Tang SCW, Tesar V, Vivarelli M, Wetzels JFM, Lytvyn L, Craig JC, Tunnicliffe DJ, Howell M, Tonelli MA, Cheung M, Earley A, Floege J. Rovin BH, et al. Kidney Int. 2021 Oct;100(4):753-779. doi: 10.1016/j.kint.2021.05.015. Kidney Int. 2021. PMID: 34556300 Free article.
The scope includes various glomerular diseases, including IgA nephropathy and IgA vasculitis, membranous nephropathy, nephrotic syndrome, minimal change disease (MCD), focal segmental glomerulosclerosis (FSGS), infection-related GN, antineutrophil cytoplasmic antibody (ANCA) vasc …
The scope includes various glomerular diseases, including IgA nephropathy and IgA vasculitis, membranous nephropathy, nephrotic syndrome, mi …
Alport Syndrome.
Nozu K, Yamamura T, Horinouchi T. Nozu K, et al. 2001 Aug 28 [updated 2025 Aug 14]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026. 2001 Aug 28 [updated 2025 Aug 14]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026. PMID: 20301386 Free Books & Documents. Review.
Kidney biopsy, skin biopsy (in some individuals with XLAS), or clinical diagnostic criteria may be used to establish the diagnosis in those without access to genetic testing or those with uninformative results. MANAGEMENT: Treatment of manifestations: Angiotensin-convertin …
Kidney biopsy, skin biopsy (in some individuals with XLAS), or clinical diagnostic criteria may be used to establish the diagnosis in those …
Anti-glomerular basement membrane antibody disease: a rare autoimmune disorder affecting the kidney and the lung.
Lahmer T, Heemann U. Lahmer T, et al. Autoimmun Rev. 2012 Dec;12(2):169-73. doi: 10.1016/j.autrev.2012.04.002. Epub 2012 Apr 23. Autoimmun Rev. 2012. PMID: 22546293 Review.
Anti-glomerular basement membrane antibody disease is a rare, but well characterized cause of glomerulonephritis. ...Therefore, standard treatment is a combined therapy of plasmapherisis, prednisolone and cyclophosphamide. The aim
Anti-glomerular basement membrane antibody disease is a rare, but well characterized cause of glomerulone
Atypical Anti-Glomerular Basement Membrane Nephritis: A Case Series From the French Nephropathology Group.
Chauveau B, Gibier JB, Olagne J, Morel A, Aydin S, McAdoo SP, Viallet N, Perrochia H, Pambrun E, Royal V, Demoulin N, Kemeny JL, Philipponnet C, Hertig A, Boffa JJ, Plaisier E, Domenger C, Brochériou I, Deltombe C, Duong Van Huyen JP, Buob D, Roufosse C, Hellmark T, Audard V, Mihout F, Nasr SH, Renaudin K, Moktefi A, Rabant M; CFPR–French Nephropathology Group. Chauveau B, et al. Am J Kidney Dis. 2024 Jun;83(6):713-728.e1. doi: 10.1053/j.ajkd.2023.11.003. Epub 2024 Jan 1. Am J Kidney Dis. 2024. PMID: 38171412
Concurrent Anti-Glomerular Basement Membrane Antibody Disease and Membranous Nephropathy: A Case Series.
Ahmad SB, Santoriello D, Canetta P, Bomback AS, D'Agati VD, Markowitz G, Ahn W, Radhakrishnan J, Appel GB. Ahmad SB, et al. Am J Kidney Dis. 2021 Aug;78(2):219-225.e1. doi: 10.1053/j.ajkd.2020.11.023. Epub 2021 Jan 7. Am J Kidney Dis. 2021. PMID: 33421452
Progression to a requirement for kidney replacement therapy occurred in all 12 patients, but 2 patients later recovered kidney function. Recurrence of anti-GBM disease did not occur for any of the patients studied. ...These findings suggest possible value from earlier diag …
Progression to a requirement for kidney replacement therapy occurred in all 12 patients, but 2 patients later recovered kidney functi …
Anti-Glomerular Basement Membrane Antibody Disease: Clinicopathologic Profile and Outcomes.
Kumar M, Jayaprakash V, Gopalakrishnan N, Dineshkumar T, Sakthirajan R, Dhanapriya J. Kumar M, et al. Indian J Nephrol. 2025 Mar-Apr;35(2):265-269. doi: 10.25259/IJN_110_2024. Epub 2024 Jun 24. Indian J Nephrol. 2025. PMID: 40060065 Free PMC article.
BACKGROUND: Anti-glomerular basement membrane antibody disease is a rare autoimmune disease caused by antibodies to alpha3 chain of type 4 collagen. Patients presenting with severe renal involvement requiring dialysis have poor response to tr
BACKGROUND: Anti-glomerular basement membrane antibody disease is a rare autoimmune disease caused by ant …
Anti-glomerular basement membrane antibody disease in Japan: part of the nationwide rapidly progressive glomerulonephritis survey in Japan.
Hirayama K, Yamagata K, Kobayashi M, Koyama A. Hirayama K, et al. Clin Exp Nephrol. 2008 Oct;12(5):339-347. doi: 10.1007/s10157-008-0051-8. Epub 2008 Apr 8. Clin Exp Nephrol. 2008. PMID: 18392773 Review.
In Japan, to improve the prognosis of patients with rapidly progressive glomerulonephritis (RPGN), we conducted a nationwide survey of patients with RPGN and investigated the initial symptoms, laboratory findings including renal biopsy findings, treatment methods, and outc …
In Japan, to improve the prognosis of patients with rapidly progressive glomerulonephritis (RPGN), we conducted a nationwide survey of patie …
Atypical anti-glomerular basement membrane disease with anti-GBM antibody negativity and ANCA positivity: a case report.
Guo N, Yin Q, Lei S, He Y, Fu P. Guo N, et al. BMC Nephrol. 2021 Feb 5;22(1):53. doi: 10.1186/s12882-021-02232-1. BMC Nephrol. 2021. PMID: 33546629 Free PMC article.
Finally, the patient was discharged successfully after treatment with plasmapheresis, methylprednisolone and prednisone. CONCLUSION: This patient, whose serum was negative for the anti-GBM antibody but positive for p-ANCA and another atypical ANCA, had a rare case of anti- …
Finally, the patient was discharged successfully after treatment with plasmapheresis, methylprednisolone and prednisone. CONCLUSION: …
435 results